Analyst Price Targets — NXTC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 11:41 am | Emily Bodnar | H.C. Wainwright | $20.00 | $6.58 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on NextCure Inc. (NXTC) |
| July 15, 2025 10:46 am | Edward Tenthoff | Piper Sandler | $15.00 | $4.76 | TheFly | NextCure price target lowered to $15 from $36 at Piper Sandler |
| June 3, 2024 8:19 am | Edward Tenthoff | Piper Sandler | $3.00 | $1.52 | StreetInsider | Piper Sandler Reiterates Overweight Rating on NextCure Inc. (NXTC) |
| November 3, 2022 9:20 pm | Edward Tenthoff | Piper Sandler | $6.00 | $2.51 | TheFly | NextCure price target lowered to $6 from $13 at Piper Sandler |
Latest News for NXTC
NextCure Inc. (NASDAQ:NXTC) on Tuesday agreed to merge with privately held biotechnology company Avere Therapeutics in an all-stock transaction that will take Avere public while providing $320 million in financing to advance its lead oral IL-23 therapy, AVR-001.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of NextCure, Inc. (NASDAQ: NXTC) PR Newswire
NEW YORK, July 14, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating NextCure, Inc. (NASDAQ: NXTC ) related to…
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders PR Newswire
MILWAUKEE, July 14, 2026 /PRNewswire/ -- Ademi LLP is investigating NextCure (NASDAQ: NXTC) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Avere Therapeutics. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NXTC.
U.S. House Trading
No House trades found for NXTC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.